{"nctId":"NCT00539305","briefTitle":"Hormone and Information Processing Study","startDateStruct":{"date":"2009-07"},"conditions":["Mild Cognitive Impairment","Alzheimer's Disease"],"count":22,"armGroups":[{"label":"Study drug; testosterone transdermal gel","type":"EXPERIMENTAL","interventionNames":["Drug: testosterone gel"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: placebo gel"]}],"interventions":[{"name":"testosterone gel","otherNames":["Solvay Testosterone Gel"]},{"name":"placebo gel","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male 60-90 years of age\n* Diagnosis of mild cognitive impairment (MCI)\n* Low testosterone level\n* Primary language is English\n* Availability of an informant who knows the participant well enough to answer questions\n* Stable medications for the previous 3 months\n* Normal complete blood count (CBC), and no clinically significant blood chemistry\n* American Urological Association (AUA) symptom score less than or equal to 19\n* Body Mass Index (BMI) less than 33 and stable weight in the previous year\n\nExclusion Criteria:\n\n* Prior history of prostate cancer or prostate specific antigen level greater than 4.0ng/ml\n* Peripheral or vascular disease\n* Significant history of alcohol abuse, current alcohol abuse (more than 2 drinks per day), or other substance abuse\n* History of severe head injury (with loss of consciousness greater than 30 minutes)\n* Significant neurological illness, such as Parkinson's disease, seizure disorder, multiple sclerosis, major stoke\n* Smokes cigarettes\n* Major psychiatric illness, such as schizophrenia or bipolar disorder\n\nProhibited Medications:\n\n* Anti-convulsants\n* Anti-psychotics\n* Sedating antihistamines\n* Sedative/hypnotics\n* Benzodiazepines\n* Hormone or testosterone regimens\n* Gonadotropin-releasing hormone (GNRH) antagonists\n* Flutamide\n* Anti-depressants and/or anti-cholinesterase inhibitors, but acceptable if on stable dose for 3 months or more","healthyVolunteers":false,"sex":"MALE","minimumAge":"60 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Behavioral & Mood Measure: Profile of Mood States (POMS)","description":"Values represent self evaluation of vigor-activity. The scale compares t-scores of participants to published norms (range 0-100), and higher scores indicate elevated emotion in subscale. Higher t-scores in vigor-activity subscale are considered favorable. Month 3 and Month 6 values display change from baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"57.7","spread":"2.2"},{"groupId":"OG001","value":"55.5","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.5","spread":"2.8"},{"groupId":"OG001","value":"-0.1","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"2.7"},{"groupId":"OG001","value":"-0.5","spread":"2.5"}]}]}]},{"type":"PRIMARY","title":"Cognitive Changes Measured by Neuropsychological Tests: Rey Auditory Verbal Learning Test","description":"Values represent total score in Long Delay Word List Recall. Higher score indicates higher level of functioning (range 0-15). Month 3 and Month 6 indicate change from baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.2","spread":"1.1"},{"groupId":"OG001","value":"4.9","spread":"1.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"0.9"},{"groupId":"OG001","value":"0.0","spread":"0.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.9"},{"groupId":"OG001","value":"1.5","spread":"0.8"}]}]}]},{"type":"PRIMARY","title":"Geriatric Depression Scale (GDS)","description":"Values represent self evaluation of depression (range 0-30). Higher scores indicate a more depressed mood. Month 3 and Month 6 indicate change from baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.2","spread":"1.3"},{"groupId":"OG001","value":"4.1","spread":"1.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"1.5"},{"groupId":"OG001","value":"2.3","spread":"1.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.8","spread":"1.5"},{"groupId":"OG001","value":"2.7","spread":"2.3"}]}]}]},{"type":"PRIMARY","title":"Short-Form Health Survey (SF-36)","description":"Self assessment of Physical Functioning in Health Survey. Higher scores indicate a higher level of functioning (range 0-100). Month 3 and 6 values represent change from baseline in subscale.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70.7","spread":"10.4"},{"groupId":"OG001","value":"85.6","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.0","spread":"9.4"},{"groupId":"OG001","value":"-3.8","spread":"6.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":"8.6"},{"groupId":"OG001","value":"-5.4","spread":"3.5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["PSA elevated above 4.0 ng/ml","Emergency room with chest pains"]}}}